Lipocine Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Lipocine Inc. (LPCN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income0.01-16.35-10.76-0.63-20.96-13.01-11.66
Depreciation & Amortization0.040.030.010.520.00-0.150.02
Stock Based Compensation0.410.650.640.601.370.000.00
Change in Working Capital-0.962.010.08-6.091.520.47-1.99
Change in Accounts Receivable-0.070.710.22-4.050.000.000.00
Change in Accounts Payable-1.120.80-0.69-0.310.410.000.00
Change in Other Working Capital0.230.50-0.24-0.241.110.000.00
Other Operating Activities-0.722.45-1.301.804.371.020.26
Net Cash from Operating Activities-1.22-11.87-11.97-4.41-15.30-11.67-12.08
Investing Activities
Capital Expenditures-0.090.010.130.010.000.000.00
Purchases of Investments-32.86-22.90-45.07-43.773.890.000.00
Sales/Maturities of Investments35.4013.1014.43-43.773.893.0011.29
Other Investing Activities0.000.000.000.000.000.000.01
Net Cash from Investing Activities2.4513.0814.29-43.783.893.0011.29
Financing Activities
Debt Repayment0.000.00-1.67-3.33-1.67-3.330.00
Common Stock Issued0.210.40-0.0226.845.655.600.65
Common Stock Repurchased0.000.00-0.020.000.000.000.00
Other Financing Activities0.000.00-0.653.419.008.000.00
Net Cash from Financing Activities0.210.40-2.1326.9220.9010.3210.65
Summary
Net Change in Cash1.431.620.20-21.279.491.659.87
Cash at Beginning of Period4.773.152.9524.2214.7313.083.21
Cash at End of Period6.214.773.152.9514.7314.7313.08
Free Cash Flow-1.31-11.88-12.10-4.42-15.30-11.67-12.08
Supplemental Disclosures
Interest Paid0.000.000.020.150.280.550.53
Income Taxes Paid0.000.000.000.000.000.000.00